Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00523237 · ClinicalTrials.gov registry record · NA

RAL-eve Study: Raltegravir Substitution Study

A NA study of HIV Infections, sponsored by Stanford University.

Completed
Registry status
NA
Development phase
14
Enrollment target
1
Study location

NCT00523237: Completed NA study of HIV Infections, sponsored by Stanford University.

NCT00523237 is a NA study of HIV Infections that has completed, run by Stanford University. The registered enrollment target is 14 participants, below the 446-participant average among 542 other HIV Infections trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00523237, a NA study of HIV Infections, has completed, sponsored by Stanford University.

COMPLETED
Registry status
NA
Development phase
14 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to: * Provide raltegravir to subjects with HIV and an undetectable viral load who are experiencing injection site reactions (ISR) to Enfuvirtide, * Monitor the safety and efficacy of raltegravir, and * Assess the change in quality of life in patients who have switched from Enfuvirtide to raltegravir

Conditions Studied

HIV Infections

Interventions

  • DRUG Raltegravir

Study Locations (1)

California

  • Stanford University School of Medicine - Stanford

Trial Details

FieldValue
Enrollment Target 14 participants
Start Date 2007-10
Est. Completion 2010-12
Phase NA

Sponsor

Stanford University

1,744 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT00523237

The ClinicalTrials.gov registry entry for NCT00523237 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 14 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 446-participant average among 542 other HIV Infections trials with a reported enrollment target (97% lower). The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with HIV Infections appearing as the primary indexed condition, and to 1 intervention - of which Raltegravir is the first listed.

NCT00523237 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT00523237 about?

NCT00523237 is a clinical study titled "RAL-eve Study: Raltegravir Substitution Study". The purpose of this study is to: * Provide raltegravir to subjects with HIV and an undetectable viral load who are experiencing injection site reactions (ISR) to Enfuvirtide, * Monitor the safety and efficacy of raltegravir, and * Assess the change in quality of life in patients who have switched f...

What is the current status of trial NCT00523237?

This trial is currently completed. It is a NA study. The enrollment target is 14 participants. The study started on 2007-10. Estimated completion is 2010-12.

What conditions does trial NCT00523237 study?

This clinical trial studies the following conditions: HIV Infections.

What interventions are being tested in trial NCT00523237?

The interventions under investigation include: Raltegravir (DRUG).

Who is sponsoring clinical trial NCT00523237?

This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00523237 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for HIV Infections

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

HIV Infections

All registered trials for this condition

California

All trials with a study site in California

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Related

Compare this shortlist side-by-side

Read our methodology - how this data is sourced, computed, and verified.
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.